As of the latest SEC filings, AIM ImmunoTech Inc. (AIM) is held by 6 institutional funds. The largest fund shareholder is Fidelity Extended Market Index Fund (FSMAX), holding an estimated $20,627.91 in market value, representing a significant portion of its portfolio.
Funds holding AIM ImmunoTech Inc. (AIM)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- AIM
- CIK:
- 0000946644
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $20,627.91 | 22,728 | Feb 28, 2026 | Apr 24, 2026 |
|
AVDE
Avantis International Equity ETF
|
ETF | American Century | 0.00% | $11,927.02 | 5,405 | Feb 28, 2026 | Apr 29, 2026 |
|
AVSD
Avantis Responsible International Equity ETF
|
ETF | American Century | 0.00% | $4,095.57 | 1,856 | Feb 28, 2026 | Apr 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $681.84 | 22,728 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $618.98 | 682 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $20.46 | 682 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)